CrossRef Cited By Search Results

This article [doi:10.1038/sj.bjc.6603376] has been cited in the following papers, taken from those publishers and societies that are participating in CrossRef's Cited-by Linking service. The number of citations from this service is usually lower than citation numbers from databases that include more journals.

1. EISSN: 15343138 ISSN: 10928480

   Current Treatment Options in Neurology

   Glioblastoma multiforme

   Mary Welch, Rose Lai

   11 (4), 2009, p.297

   doi:10.1007/s11940-009-0033-5

2. EISSN: 15737373 ISSN: 0167594X

   Journal of Neuro-Oncology

   Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study

   Mario Balducci et al.

   doi:10.1007/s11060-009-9997-y

3. EISSN: 18655076 ISSN: 18655041

   memo - Magazine of European Medical Oncology

   Temozolomide – what regimen in what situation?

   P. Hau

   2 (s3), 2009, p.8

   doi:10.1007/s12254-009-0127-5

4. EISSN: 15737373 ISSN: 0167594X

   Journal of Neuro-Oncology

   Extended-schedule dose-dense temozolomide in refractory gliomas

   A. Berrocal et al.

   doi:10.1007/s11060-009-9980-7

5. EISSN: 15698041 ISSN: 09237534

   Annals of Oncology

   Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study

   S. Siena et al.

   doi:10.1093/annonc/mdp343

6. EISSN: 17594782 ISSN: 17594774

   Nature Reviews Clinical Oncology

   New advances that enable identification of glioblastoma recurrence

   Isaac Yang, Manish K. Aghi

   6 (11), 2009, p.648

   doi:10.1038/nrclinonc.2009.150

7. ISSN: 13507540

   Current Opinion in Neurology

   Classification and management of anaplastic gliomas :

   Wolfgang Wick, Michael Weller

   22 (6), 2009, p.650

   doi:10.1097/WCO.0b013e3283329ce7

8. EISSN: 15737373 ISSN: 0167594X

   Journal of Neuro-Oncology

   Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patients

   Antonio Silvani et al.

   87 (2), 2008, p.143

   doi:10.1007/s11060-007-9427-y

9. EISSN: 10970215 ISSN: 00207136

   International Journal of Cancer

   MGMT in primary and recurrent human glioblastomas after radiation and chemotherapy and comparison with p53 status and clinical outcome

   Dorothee Wiewrodt et al.

   122 (6), 2008, p.1391

   doi:10.1002/ijc.23219

10. EISSN: 17447666 ISSN: 14656566

    Expert Opinion on Pharmacotherapy

    Management of glioblastoma

    Tomokazu Aoki, Nobuo Hashimoto, Masao Matsutani

    8 (18), 2007, p.3133

    doi:10.1517/14656566.8.18.3133

11. EISSN: 17448336 ISSN: 14787210

    Expert Review of Anticancer Therapy

    Adjuvant temozolomide: how long and how much?

    Enrico Franceschi, Alicia Tosoni, Alba A Brandes

    8 (5), 2008, p.663

    doi:10.1586/14737140.8.5.663

12. EISSN: 14230240 ISSN: 0378584X

    Onkologie

    Temozolomide in Newly Diagnosed Malignant Gliomas: Administered Concomitantly with Radiotherapy, and Thereafter as Consolidation Treatment

    Emel Yaman et al.

    31 (6), 2008, p.309

    doi:10.1159/000127252

13. EISSN: 15737373 ISSN: 0167594X

    Journal of Neuro-Oncology

    Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas

    A. Tosoni et al.

    89 (2), 2008, p.179

    doi:10.1007/s11060-008-9600-y

14. EISSN: 15737373 ISSN: 0167594X

    Journal of Neuro-Oncology

    Dose-intensity temozolomide after concurrent chemoradiotherapy in operated high-grade gliomas

    Stefano Dall’Oglio et al.

    90 (3), 2008, p.315

    doi:10.1007/s11060-008-9663-9

15. EISSN: 17448336 ISSN: 14787210

    Expert Review of Anticancer Therapy

    Association between response to primary treatments and MGMT status in glioblastoma

    Enrico Franceschi, Alicia Tosoni, Eugenio Pozzati, Alba A Brandes

    8 (11), 2008, p.1781

    doi:10.1586/14737140.8.11.1781

16. EISSN: 15737373 ISSN: 0167594X

    Journal of Neuro-Oncology

    Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy

    Jennifer A. Quinn et al.

    95 (3), 2009, p.393

    doi:10.1007/s11060-009-9937-x

17. EISSN: 14321459 ISSN: 03405354

    Journal of Neurology

    Rechallenge with temozolomide in patients with recurrent gliomas

    Antje Wick et al.

    256 (5), 2009, p.734

    doi:10.1007/s00415-009-5006-9

18. EISSN: 14320843 ISSN: 03445704

    Cancer Chemotherapy and Pharmacology

    Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)

    Alba A. Brandes et al.

    64 (4), 2009, p.769

    doi:10.1007/s00280-009-0926-8

19. EISSN: 1439099X ISSN: 01797158

    Strahlentherapie und Onkologie

    Hypofractionated reirradiation for recurrent malignant glioma

    Guido Henke et al.

    185 (2), 2009, p.113

    doi:10.1007/s00066-009-1969-9

20. ISSN: 13507540

    Current Opinion in Neurology

    Editorial: what is new in the treatment of gliomas?

    Antonio M Omuro, Jean-Yves Delattre

    20 (6), 2007, p.704

    doi:10.1097/WCO.0b013e3282f1beef

21. EISSN: 13475231 ISSN: 00316903

    YAKUGAKU ZASSHI

    Evaluation of Stability of Temozolomide in Solutions after Opening the Capsule

    Takaaki KODAWARA et al.

    129 (3), 2009, p.353

    doi:10.1248/yakushi.129.353

22. ISSN: 10408746

    Current Opinion in Oncology

    Molecular genetic markers as predictors of response to chemotherapy in gliomas

    Ahmed Idbaih, Antonio Omuro, François Ducray, Khê Hoang-Xuan

    19 (6), 2007, p.606

    doi:10.1097/CCO.0b013e3282f075f3

23. EISSN: 1866587X ISSN: 18665861

    Onkopipeline

    Tumorprogress versus therapieinduzierte Veränderungen (Pseudoprogression) bei malignen Astrozytomen

    Michael Platten

    2 (1), 2009, p.16

    doi:10.1007/s15035-009-0139-y